Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

10.69 +0.92 (+9.42%)

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Recap: Gossamer Bio Q3 Earnings ↗

November 09, 2023

Via Benzinga

Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update

November 09, 2023

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

October 03, 2023

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023

September 07, 2023

From Gossamer Bio, Inc.

Via Business Wire

Analyst Expectations for Gossamer Bio's Future ↗

August 11, 2023

Via Benzinga

Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update

August 08, 2023

From Gossamer Bio, Inc.

Via Business Wire

Analyst Ratings for Gossamer Bio ↗

July 26, 2023

Via Benzinga

Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results

July 24, 2023

From Gossamer Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 20, 2023

Via Benzinga

After Pausing Recruitment, Gossamer Bio Terminates All Studies With CNS Lymphoma Candidate ↗

April 04, 2023

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

March 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 20, 2023

Via Benzinga

Gossamer Bio Announces $212 Million Private Placement Financing

July 20, 2023

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference

May 18, 2023

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update

May 09, 2023

From Gossamer Bio, Inc.

Via Business Wire

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

Skillz And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

April 06, 2023

The Dow Jones closed higher by around 80 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 20, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 20, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 20, 2023

It's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement!

Via InvestorPlace

Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

March 17, 2023

From Gossamer Bio, Inc.

Via Business Wire

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 13, 2023

Via Benzinga

Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

7 Top Short-Squeeze Candidates to Watch in February ↗

February 01, 2023

For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.

Via InvestorPlace

Looking Into Gossamer Bio's Recent Short Interest ↗

January 03, 2023

Gossamer Bio's (NASDAQ:GOSS) short percent of float has fallen 32.89% since its last report. The company recently reported that it has 14.41 million shares sold short, which is 17.59% of all regular...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.